Periodic Reporting for period 1 - RESIST3D (Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids)

Ovarian cancer is the fifth leading cause of cancer death among women in Europe. Despite the fact that standard chemotherapeutic agents, used as a first-line therapy, are very effective in eliminating a vast majority of bulk ovarian cancer cells thereby inducing remission, 80%...